Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

A growing number of young, non-diabetic Hyderabadis are being diagnosed with CKDu — a mysterious kidney disease with no clear ...

Researchers from Aarhus University have discovered a protein that can predict whether kidney cells will survive or die after acute injury. The finding could pave the way for new treatments and benefit ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective ...

Scientists achieve scalable human kidney organoid production and integration into pig kidneys, a milestone in regenerative medicine.

The Korea Institute of Ocean Science and Technology (KIOST), led by President Lee Heeseung, in collaboration with Professor ...

Novel nephron organoids that can be fine-tuned to represent the proximal convoluted tubule or loop of Henle have been ...

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...